SANDLER LAURA LEE (Chief Operating Officer) sold 2.1% of their position (5K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $167.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/2/2026ACC: 0000907654-26-000022
Officer· Chief Operating Officer
Since Mar 2026
-5K
Net shares
Net seller
$167.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5K
Price / share
$7.80
Trade value
$39K
% of position
2.1%
3/2/2026
237.58K→242.58K
Common Stock
Direct
Shares
−2.33K
Price / share
$33.28
Trade value
$77.39K
% of position
1.0%
3/2/2026
242.58K→240.26K
Common Stock
Direct
Shares
−2.67K
Price / share
$33.81
Trade value
$90.44K
% of position
1.1%
3/2/2026
240.26K→237.58K
Total
Net shares
+0.00
Net value
-$128.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | M · Option Exercise | +5K | $7.80 | $39K | 2.1% | 237.58K | 242.58K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.33K | $33.28 | $77.39K | 1.0% | 242.58K | 240.26K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.67K | $33.81 | $90.44K | 1.1% | 240.26K | 237.58K |
| Total | +0.00 | -$128.82K | ||||||
Derivative Transactions1
Employee Warrant (right to buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
7.80
Held after
90K
Exercisable
—
3/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock5K shares | 3/2/2026 | M · Option Exercise | −5K | 7.80 | — | 90K |